Noora Houttu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Noora Houttu has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Kirsi Laitinen
University of Turku
19 shared publications - Kati Mokkala
Nutrition and Food Research Center University of Turku Turku Finland
9 shared publications - Ella Koivuniemi
Integrative Physiology and Pharmacology Unit, Institute of Biomedicine University of Turku Turku Finland
8 shared publications - Tero Vahlberg
Department of Biostatistics, University of Turku, Turku, Finland
8 shared publications - Kristiina Tertti
Department of Obstetrics and Gynaecology University of Turku and Turku University Hospital Turku Finland
4 shared publications - Leo Lahti
Department of Computing, University of Turku, Turku, Finland
4 shared publications
Latest Publications
- Open Access
- 28 February 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2635205
Changes in hemoglobin levels and cardiometabolic health in adults with metabolic syndrome – a secondary outcome analysis of a six-month randomized controlled trial
Red blood cells (RBCs) and their hemoglobin (Hb) are essential components for transporting oxygen to peripheral tissues in the human body and therefore play a crucial part in energy metabolism. Thi...
- 28 February 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2635205
Open AccessChanges in hemoglobin levels and cardiometabolic health in adults with metabolic syndrome – a secondary outcome analysis of a six-month randomized controlled trial
Red blood cells (RBCs) and their hemoglobin (Hb) are essential components for transporting oxygen to peripheral tissues in the human body and therefore play a crucial part in energy metabolism. Thi...
- Open Access
- 12 November 2025
- Published by Wiley in Microbiologyopen
- Vol. 14 (6) , e70128
The Relationship Between Gut Microbiota During Pregnancy and the Level of Postpartum Adiposity
Gut microbiota is linked with health, including obesity, in the general population. It is unknown whether adiposity at postpartum is influenced by gut microbiota already during pregnancy. We investigated the association between the gut microbiota's composition and predicted function by metagenomics during pregnancy and the women's adiposity (body mass index [BMI], waist‐to‐hip ratio [WHR], body fat%) assessed at 1‐, 2‐, and 5–6‐years' postpartum in 257 women with overweight or obesity based on prepregnancy BMI values. Body fat% at 1‐year, but not at 2‐ or 5–6‐years' postpartum, was associated inversely with α ‐diversity during pregnancy. Bacterial species GGB3034 SGB4030 (family Erysipelotrichaceae ) was higher in women with normal weight than those in women with obesity at 1‐year postpartum ( q = 0.02), other species being borderline statistically significant ( q < 0.25). High WHR and body fat% at 1‐year postpartum were associated with two species ( q < 0.25). Considering predicted functions of bacteria, an association was detected for BMI, WHR, and body fat%, e.g., body fat% and glycogen biosynthesis I ( q < 0.25). Gut microbiota during pregnancy predicted the BMI and body fat% at 1‐year postpartum (ROC > 0.50, p < 0.02). Postpartum adiposity was associated with several species and α ‐diversity. Gut microbiota during pregnancy may be involved in the persistence of obesity and its comorbidities after pregnancy.
- 12 November 2025
- Published by Wiley in Microbiologyopen
- Vol. 14 (6) , e70128
Open AccessThe Relationship Between Gut Microbiota During Pregnancy and the Level of Postpartum Adiposity
Gut microbiota is linked with health, including obesity, in the general population. It is unknown whether adiposity at postpartum is influenced by gut microbiota already during pregnancy. We investigated the association between the gut microbiota's composition and predicted function by metagenomics during pregnancy and the women's adiposity (body mass index [BMI], waist‐to‐hip ratio [WHR], body fat%) assessed at 1‐, 2‐, and 5–6‐years' postpartum in 257 women with overweight or obesity based on prepregnancy BMI values. Body fat% at 1‐year, but not at 2‐ or 5–6‐years' postpartum, was associated inversely with α ‐diversity during pregnancy. Bacterial species GGB3034 SGB4030 (family Erysipelotrichaceae ) was higher in women with normal weight than those in women with obesity at 1‐year postpartum ( q = 0.02), other species being borderline statistically significant ( q < 0.25). High WHR and body fat% at 1‐year postpartum were associated with two species ( q < 0.25). Considering predicted functions of bacteria, an association was detected for BMI, WHR, and body fat%, e.g., body fat% and glycogen biosynthesis I ( q < 0.25). Gut microbiota during pregnancy predicted the BMI and body fat% at 1‐year postpartum (ROC > 0.50, p < 0.02). Postpartum adiposity was associated with several species and α ‐diversity. Gut microbiota during pregnancy may be involved in the persistence of obesity and its comorbidities after pregnancy.
- Open Access
- 13 October 2025
- Published by Wiley in Obesity Science & Practice
- Vol. 11 (5)
Postpartum Body Composition in Women With Overweight: Associations With Diet During Pregnancy
Objective: Weight management during the first few years postpartum is considered important for the prevention of future metabolic disturbances. Body fat percentage measured using air displacement plethysmography is an accurate marker of body adiposity. In this secondary analysis of a randomized controlled trial, the aims were to identify distinctive body fat percentage trajectories up to 2 years postpartum in women with overweight and to investigate whether fish oil and/or probiotic supplements, diet, gestational diabetes, or gestational weight gain influenced the body composition. Methods: Women with overweight or obesity ( n = 439) were randomized to receive fish oil (1.9 g docosahexaenoic acid and 0.22 g eicosapentaenoic acid) and/or probiotics ( Lacticaseibacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis 420, 10 10 CFU each) in a double‐blind manner from early pregnancy until 6 months postpartum. Body composition ( n = 329) was measured using air displacement plethysmography, at three, six, 12, and 24 months postpartum. Diet in early pregnancy was evaluated using nutrient intakes, dietary patterns, and the Index of Diet Quality (IDQ) questionnaire. Results: Three postpartum body fat percentage trajectories were identified, but none displayed a sustained decrease in adiposity. A healthy dietary pattern (adjusted OR 5.8 [95% CI 2.5–13.5], p < 0.001) and high IDQ score (adjusted OR 2.5 [95% CI 1.1–5.5], p = 0.023) in early pregnancy increased the odds of a decreasing trend during the first postpartum year. The fish oil and/or probiotic intervention did not impact the body composition. Conclusion: Good overall dietary quality during pregnancy may benefit the body composition of women with overweight or obesity at postpartum. Trial Registration: NCT01922791, ClinicalTrials.gov
- 13 October 2025
- Published by Wiley in Obesity Science & Practice
- Vol. 11 (5)
Open AccessPostpartum Body Composition in Women With Overweight: Associations With Diet During Pregnancy
Objective: Weight management during the first few years postpartum is considered important for the prevention of future metabolic disturbances. Body fat percentage measured using air displacement plethysmography is an accurate marker of body adiposity. In this secondary analysis of a randomized controlled trial, the aims were to identify distinctive body fat percentage trajectories up to 2 years postpartum in women with overweight and to investigate whether fish oil and/or probiotic supplements, diet, gestational diabetes, or gestational weight gain influenced the body composition. Methods: Women with overweight or obesity ( n = 439) were randomized to receive fish oil (1.9 g docosahexaenoic acid and 0.22 g eicosapentaenoic acid) and/or probiotics ( Lacticaseibacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis 420, 10 10 CFU each) in a double‐blind manner from early pregnancy until 6 months postpartum. Body composition ( n = 329) was measured using air displacement plethysmography, at three, six, 12, and 24 months postpartum. Diet in early pregnancy was evaluated using nutrient intakes, dietary patterns, and the Index of Diet Quality (IDQ) questionnaire. Results: Three postpartum body fat percentage trajectories were identified, but none displayed a sustained decrease in adiposity. A healthy dietary pattern (adjusted OR 5.8 [95% CI 2.5–13.5], p < 0.001) and high IDQ score (adjusted OR 2.5 [95% CI 1.1–5.5], p = 0.023) in early pregnancy increased the odds of a decreasing trend during the first postpartum year. The fish oil and/or probiotic intervention did not impact the body composition. Conclusion: Good overall dietary quality during pregnancy may benefit the body composition of women with overweight or obesity at postpartum. Trial Registration: NCT01922791, ClinicalTrials.gov
- Open Access
- 10 September 2025
- Published by Elsevier in Current Developments in Nutrition
- Vol. 9 (10)
The Impact of Maternal Supplementation of Fish Oil and/or Probiotics During Pregnancy on the Serum Metabolomic Profile From Infancy to Childhood: Secondary Analysis of a Randomized Placebo-Controlled Trial
- 10 September 2025
- Published by Elsevier in Current Developments in Nutrition
- Vol. 9 (10)
Open AccessThe Impact of Maternal Supplementation of Fish Oil and/or Probiotics During Pregnancy on the Serum Metabolomic Profile From Infancy to Childhood: Secondary Analysis of a Randomized Placebo-Controlled Trial
- Open Access
- 9 June 2025
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 81 (2) , 355-366
Maternal diet and gestational diabetes mellitus modestly influence children's growth during their first 24 months
Objective: To evaluate whether diet and gestational diabetes mellitus (GDM) during pregnancy influence children's growth during their first 24 months.Methods: Growth data of children (n = 378) of women with overweight/obesity were obtained from clinic records (birth, 3, 6, 12 and 24 months), and variables (standard deviation scores (SDS) or percentages) were calculated based on Finnish growth charts. Body composition was measured by air displacement plethysmography (n = 73, 24 months). Diet was assessed (diet quality index, nutrient intakes and diet inflammatory index (DII®)) in early and late pregnancy. GDM was determined by an oral glucose tolerance test.Results: A good dietary quality in early pregnancy associated positively with the children's height at each time point (adj. mean difference range = 0.28–0.30 SDS, p < 0.05) and head circumference at 12 and 24 months (adj. mean difference range = 0.38–0.42 SDS, p < 0.05). A good dietary quality in late pregnancy associated with a lower fat mass in children (adj. mean difference = −0.69, p < 0.05). A higher DII was correlated with a higher weight at 24 months but a reduced height at each time point (adj. p < 0.05). GDM associated negatively with the children's head circumference at birth and 6 months (adj. mean difference range = −0.43 to [−0.22] SDS, p < 0.05).Conclusions: Consuming a good quality diet during pregnancy associated with a greater infantile height and head circumference but a lower adiposity in 2‐year‐old children. GDM may lead to a slightly smaller head circumference in early infancy. Mothers with overweight or obesity could support their children's growth by consuming a good quality diet, with low inflammatory potential during pregnancy.Trial Registration: ClinicalTrials.gov Identifier: NCT01922791, 14 August 2013.
- 9 June 2025
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 81 (2) , 355-366
Open AccessMaternal diet and gestational diabetes mellitus modestly influence children's growth during their first 24 months
Objective: To evaluate whether diet and gestational diabetes mellitus (GDM) during pregnancy influence children's growth during their first 24 months.Methods: Growth data of children (n = 378) of women with overweight/obesity were obtained from clinic records (birth, 3, 6, 12 and 24 months), and variables (standard deviation scores (SDS) or percentages) were calculated based on Finnish growth charts. Body composition was measured by air displacement plethysmography (n = 73, 24 months). Diet was assessed (diet quality index, nutrient intakes and diet inflammatory index (DII®)) in early and late pregnancy. GDM was determined by an oral glucose tolerance test.Results: A good dietary quality in early pregnancy associated positively with the children's height at each time point (adj. mean difference range = 0.28–0.30 SDS, p < 0.05) and head circumference at 12 and 24 months (adj. mean difference range = 0.38–0.42 SDS, p < 0.05). A good dietary quality in late pregnancy associated with a lower fat mass in children (adj. mean difference = −0.69, p < 0.05). A higher DII was correlated with a higher weight at 24 months but a reduced height at each time point (adj. p < 0.05). GDM associated negatively with the children's head circumference at birth and 6 months (adj. mean difference range = −0.43 to [−0.22] SDS, p < 0.05).Conclusions: Consuming a good quality diet during pregnancy associated with a greater infantile height and head circumference but a lower adiposity in 2‐year‐old children. GDM may lead to a slightly smaller head circumference in early infancy. Mothers with overweight or obesity could support their children's growth by consuming a good quality diet, with low inflammatory potential during pregnancy.Trial Registration: ClinicalTrials.gov Identifier: NCT01922791, 14 August 2013.
- Open Access
- 24 December 2024
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 83 (7) , e1917-e1938
Diet–Gut Microbiota Relations: Critical Appraisal of Evidence From Studies Using Metagenomics
Diet may influence the gut microbiota and subsequently affect the host’s health. Recent developments in methods analyzing the composition and function of the gut microbiota allow a deeper understanding of diet–gut microbiota relationships. A state-of-the-art methodology, shotgun metagenomics sequencing, offers a higher taxonomic resolution of the gut microbiota at the bacterial species and strain levels, and more accurate information regarding the functional potential of gut microbiota. Here, the available evidence on the relationship between diet and gut microbiota was critically reviewed, focusing on results emerging from recent metagenomics sequencing studies applied in randomized controlled trials and observational studies. The PubMed and Embase databases were used to search publications between January 2011 and September 2023. Thus far, the number of studies is limited, and the study designs and methods utilized have been variable. Nevertheless, the cumulative evidence from interventions relates to dietary fiber as a modifier of bacterial species, such as Anaerostipes hadrus and Faecalibacterium prausnitzii. Furthermore, observational studies have detected associations between different dietary patterns and food groups with certain microbial species. Utilization of metagenomics sequencing is becoming more common and will undoubtedly provide further insights into diet–gut microbiota relationships at the species level as well as their functional pathways in the near future. For reproducible results and to draw reliable conclusions across various studies on diet–gut microbiota relationships, there is a need for harmonization of the study designs and standardized ways of reporting.
- 24 December 2024
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 83 (7) , e1917-e1938
Open AccessDiet–Gut Microbiota Relations: Critical Appraisal of Evidence From Studies Using Metagenomics
Diet may influence the gut microbiota and subsequently affect the host’s health. Recent developments in methods analyzing the composition and function of the gut microbiota allow a deeper understanding of diet–gut microbiota relationships. A state-of-the-art methodology, shotgun metagenomics sequencing, offers a higher taxonomic resolution of the gut microbiota at the bacterial species and strain levels, and more accurate information regarding the functional potential of gut microbiota. Here, the available evidence on the relationship between diet and gut microbiota was critically reviewed, focusing on results emerging from recent metagenomics sequencing studies applied in randomized controlled trials and observational studies. The PubMed and Embase databases were used to search publications between January 2011 and September 2023. Thus far, the number of studies is limited, and the study designs and methods utilized have been variable. Nevertheless, the cumulative evidence from interventions relates to dietary fiber as a modifier of bacterial species, such as Anaerostipes hadrus and Faecalibacterium prausnitzii. Furthermore, observational studies have detected associations between different dietary patterns and food groups with certain microbial species. Utilization of metagenomics sequencing is becoming more common and will undoubtedly provide further insights into diet–gut microbiota relationships at the species level as well as their functional pathways in the near future. For reproducible results and to draw reliable conclusions across various studies on diet–gut microbiota relationships, there is a need for harmonization of the study designs and standardized ways of reporting.
- Open Access
- 29 August 2023
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 131 (2) , 296-311
The impact of fish oil and/or probiotics on serum fatty acids and the interaction with low-grade inflammation in pregnant women with overweight and obesity: secondary analysis of a randomised controlled trial
N-3 long-chain PUFA (LC-PUFA) and probiotics are generally considered to induce health benefits. The objective was to investigate (1) the impact of fish oil and/or probiotics on serum fatty acids (sFA), (2) the interaction of sFA with low-grade inflammation and (3) the relation of sFA to the onset of gestational diabetes mellitus (GDM). Pregnant women with overweight/obesity were allocated into intervention groups with fish oil + placebo, probiotics + placebo, fish oil + probiotics or placebo + placebo in early pregnancy (fish oil: 1·9 g DHA and 0·22 g EPA, probiotics: Lacticaseibacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis 420, 1010 CFU, each daily). Blood samples were collected in early (n 431) and late pregnancy (n 361) for analysis of fatty acids in serum phosphatidylcholine (PC), cholesteryl esters (CE), TAG and NEFA with GC and high-sensitivity C-reactive protein and GlycA by immunoassay and NMR spectroscopy, respectively. GDM was diagnosed according to 2 h 75 g oral glucose tolerance test. EPA in PC, CE and TAG and DHA in PC, CE, TAG and NEFA were higher in fish oil and fish oil + probiotics groups compared with placebo. EPA in serum NEFA was lower in women receiving probiotics compared with women not receiving. Low-grade inflammation was inversely associated with n-3 LC-PUFA, which were related to an increased risk of GDM. Fish oil and fish oil + probiotics consumption increase serum n-3 LC-PUFA in pregnant women with overweight/obesity. Although these fatty acids were inversely related to inflammatory markers, n-3 LC-PUFA were linked with an increased risk for GDM.
- 29 August 2023
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 131 (2) , 296-311
Open AccessThe impact of fish oil and/or probiotics on serum fatty acids and the interaction with low-grade inflammation in pregnant women with overweight and obesity: secondary analysis of a randomised controlled trial
N-3 long-chain PUFA (LC-PUFA) and probiotics are generally considered to induce health benefits. The objective was to investigate (1) the impact of fish oil and/or probiotics on serum fatty acids (sFA), (2) the interaction of sFA with low-grade inflammation and (3) the relation of sFA to the onset of gestational diabetes mellitus (GDM). Pregnant women with overweight/obesity were allocated into intervention groups with fish oil + placebo, probiotics + placebo, fish oil + probiotics or placebo + placebo in early pregnancy (fish oil: 1·9 g DHA and 0·22 g EPA, probiotics: Lacticaseibacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis 420, 1010 CFU, each daily). Blood samples were collected in early (n 431) and late pregnancy (n 361) for analysis of fatty acids in serum phosphatidylcholine (PC), cholesteryl esters (CE), TAG and NEFA with GC and high-sensitivity C-reactive protein and GlycA by immunoassay and NMR spectroscopy, respectively. GDM was diagnosed according to 2 h 75 g oral glucose tolerance test. EPA in PC, CE and TAG and DHA in PC, CE, TAG and NEFA were higher in fish oil and fish oil + probiotics groups compared with placebo. EPA in serum NEFA was lower in women receiving probiotics compared with women not receiving. Low-grade inflammation was inversely associated with n-3 LC-PUFA, which were related to an increased risk of GDM. Fish oil and fish oil + probiotics consumption increase serum n-3 LC-PUFA in pregnant women with overweight/obesity. Although these fatty acids were inversely related to inflammatory markers, n-3 LC-PUFA were linked with an increased risk for GDM.
- Open Access
- 28 April 2023
- Published by Springer Nature in Acta Diabetologica
- Vol. 60 (8) , 1045-1054
Gut microbiota composition and function in pregnancy as determinants of prediabetes at two-year postpartum
Aims: Deep metagenomics offers an advanced tool for examining the relationship between gut microbiota composition and function and the onset of disease; in this case, does the composition and function of gut microbiota during pregnancy differ in women who develop prediabetes and those who do not at two-year postpartum, and whether the gut microbiota composition associates with glycemic traits. Methods: In total, 439 women were recruited in early pregnancy. Gut microbiota was assessed by metagenomics analysis in early (13.9 ± 2.0 gestational weeks) and late pregnancy (35.1 ± 1.0 gestational weeks). Prediabetes was determined using American Diabetes Association criteria as fasting plasma glucose 5.6–6.9 mmol/l analyzed by an enzymatic hexokinase method. Of the women, 39 (22.1%) developed prediabetes by two-year postpartum. Results: The relative abundances of Escherichia unclassified (FDR < 0.05), Clostridiales bacterium 1_7_ 47FAA (FDR < 0.25) and Parabacteroides (FDR < 0.25) were higher, and those of Ruminococcaceae bacterium D16 (FDR < 0.25), Anaerotruncus unclassified (FDR < 0.25) and Ruminococcaceae noname (FDR < 0.25) were lower in early pregnancy in those women who later developed prediabetes. In late pregnancy, Porphyromonas was higher and Ruminococcus sp 5_1_39BFAA was lower in prediabetes (FDR < 0.25). Furthermore, fasting glucose concentrations associated inversely with Anaerotruncus unclassified in early pregnancy and directly with Ruminococcus sp 5_1_39BFAA in late pregnancy (FDR < 0.25). α-Diversity or β-diversity did not differ significantly between the groups. Predictions of community function during pregnancy were not associated with prediabetes. Conclusions: Our study shows that some bacterial species during pregnancy contributed to the onset of prediabetes within two-year postpartum. These were attributable primarily to a lower abundance of short-chain fatty acids-producing bacteria.
- 28 April 2023
- Published by Springer Nature in Acta Diabetologica
- Vol. 60 (8) , 1045-1054
Open AccessGut microbiota composition and function in pregnancy as determinants of prediabetes at two-year postpartum
Aims: Deep metagenomics offers an advanced tool for examining the relationship between gut microbiota composition and function and the onset of disease; in this case, does the composition and function of gut microbiota during pregnancy differ in women who develop prediabetes and those who do not at two-year postpartum, and whether the gut microbiota composition associates with glycemic traits. Methods: In total, 439 women were recruited in early pregnancy. Gut microbiota was assessed by metagenomics analysis in early (13.9 ± 2.0 gestational weeks) and late pregnancy (35.1 ± 1.0 gestational weeks). Prediabetes was determined using American Diabetes Association criteria as fasting plasma glucose 5.6–6.9 mmol/l analyzed by an enzymatic hexokinase method. Of the women, 39 (22.1%) developed prediabetes by two-year postpartum. Results: The relative abundances of Escherichia unclassified (FDR < 0.05), Clostridiales bacterium 1_7_ 47FAA (FDR < 0.25) and Parabacteroides (FDR < 0.25) were higher, and those of Ruminococcaceae bacterium D16 (FDR < 0.25), Anaerotruncus unclassified (FDR < 0.25) and Ruminococcaceae noname (FDR < 0.25) were lower in early pregnancy in those women who later developed prediabetes. In late pregnancy, Porphyromonas was higher and Ruminococcus sp 5_1_39BFAA was lower in prediabetes (FDR < 0.25). Furthermore, fasting glucose concentrations associated inversely with Anaerotruncus unclassified in early pregnancy and directly with Ruminococcus sp 5_1_39BFAA in late pregnancy (FDR < 0.25). α-Diversity or β-diversity did not differ significantly between the groups. Predictions of community function during pregnancy were not associated with prediabetes. Conclusions: Our study shows that some bacterial species during pregnancy contributed to the onset of prediabetes within two-year postpartum. These were attributable primarily to a lower abundance of short-chain fatty acids-producing bacteria.
- Open Access
- 13 October 2022
- Published by Wolters Kluwer Health in Medicine & Science in Sports & Exercise
- Vol. 55 (3) , 342-353
Reducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial
Purpose: This study aimed to investigate whether a reduction in daily sedentary behavior (SB) improves insulin sensitivity in adults with metabolic syndrome in 6 months, without adding intentional exercise training. Methods: Sixty-four sedentary inactive middle-age adults with overweight and metabolic syndrome (mean (SD) age, 58 (7) yr; mean (SD) body mass index, 31.6 (4.3) kg·m−2; 27 men) were randomized into intervention and control groups. The 6-month individualized behavioral intervention supported by an interactive accelerometer and a mobile application aimed at reducing daily SB by 1 h compared with baseline. Insulin sensitivity by hyperinsulinemic euglycemic clamp, body composition by air displacement plethysmography, and fasting blood samples were analyzed before and after the intervention. SB and physical activity were measured with hip-worn accelerometers throughout the intervention. Results: SB decreased by 40 (95% confidence interval, 17–65) min·d−1, and moderate-to-vigorous physical activity increased by 20 (95% confidence interval, 11–28) min·d−1 on average in the intervention group with no significant changes in these outcomes in the control group. After 6 months, fasting plasma insulin decreased (~1 mU·L−1) in the intervention group compared with the control group (time–group, P = 0.0081), but insulin sensitivity did not change in either group. The changes in body mass or adiposity did not differ between groups. Among all participants, the changes in SB and body mass correlated inversely with the change in insulin sensitivity (r = −0.31, −0.44; P = 0.025, 0.0005, respectively). Conclusions: An intervention aimed at reducing daily SB resulted in slightly decreased fasting insulin, but had no effects on insulin sensitivity or body adiposity. However, as the change in insulin sensitivity associated with the changes in SB and body mass, multifaceted interventions targeting to weight loss are likely to be beneficial in improving whole-body insulin sensitivity.
- 13 October 2022
- Published by Wolters Kluwer Health in Medicine & Science in Sports & Exercise
- Vol. 55 (3) , 342-353
Open AccessReducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial
Purpose: This study aimed to investigate whether a reduction in daily sedentary behavior (SB) improves insulin sensitivity in adults with metabolic syndrome in 6 months, without adding intentional exercise training. Methods: Sixty-four sedentary inactive middle-age adults with overweight and metabolic syndrome (mean (SD) age, 58 (7) yr; mean (SD) body mass index, 31.6 (4.3) kg·m−2; 27 men) were randomized into intervention and control groups. The 6-month individualized behavioral intervention supported by an interactive accelerometer and a mobile application aimed at reducing daily SB by 1 h compared with baseline. Insulin sensitivity by hyperinsulinemic euglycemic clamp, body composition by air displacement plethysmography, and fasting blood samples were analyzed before and after the intervention. SB and physical activity were measured with hip-worn accelerometers throughout the intervention. Results: SB decreased by 40 (95% confidence interval, 17–65) min·d−1, and moderate-to-vigorous physical activity increased by 20 (95% confidence interval, 11–28) min·d−1 on average in the intervention group with no significant changes in these outcomes in the control group. After 6 months, fasting plasma insulin decreased (~1 mU·L−1) in the intervention group compared with the control group (time–group, P = 0.0081), but insulin sensitivity did not change in either group. The changes in body mass or adiposity did not differ between groups. Among all participants, the changes in SB and body mass correlated inversely with the change in insulin sensitivity (r = −0.31, −0.44; P = 0.025, 0.0005, respectively). Conclusions: An intervention aimed at reducing daily SB resulted in slightly decreased fasting insulin, but had no effects on insulin sensitivity or body adiposity. However, as the change in insulin sensitivity associated with the changes in SB and body mass, multifaceted interventions targeting to weight loss are likely to be beneficial in improving whole-body insulin sensitivity.
- Open Access
- 28 March 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 149, 112841
Potential pathobionts in vaginal microbiota are affected by fish oil and/or probiotics intervention in overweight and obese pregnant women
- 28 March 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 149, 112841
Open AccessPotential pathobionts in vaginal microbiota are affected by fish oil and/or probiotics intervention in overweight and obese pregnant women